| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:1901534 | BP | positive regulation of hematopoietic progenitor cell differentiation | Any process that activates or increases the frequency, rate or extent of hematopoietic progenitor cell differentiation. |
FOXC1 |
GO:1901536 | BP | negative regulation of DNA demethylation | Any process that stops, prevents or reduces the frequency, rate or extent of DNA demethylation. |
TRIM28 |
GO:1901558 | BP | response to metformin | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metformin stimulus. |
PPARG, PPARGC1A |
GO:1901581 | BP | negative regulation of telomeric RNA transcription from RNA pol II promoter | Any process that stops, prevents or reduces the frequency, rate or extent of telomeric RNA transcription from RNA pol II promoter. |
ATRX |
GO:1901582 | BP | positive regulation of telomeric RNA transcription from RNA pol II promoter | Any process that activates or increases the frequency, rate or extent of telomeric RNA transcription from RNA pol II promoter. |
ATRX |
GO:1901585 | BP | regulation of acid-sensing ion channel activity | Any process that modulates the frequency, rate or extent of acid-sensing ion channel activity. |
STOM |
GO:1901594 | BP | response to capsazepine | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a capsazepine stimulus. |
TRPV1 |
GO:1901620 | BP | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning | Any process that modulates the frequency, rate or extent of smoothened signaling pathway involved in dorsal/ventral neural tube patterning. |
MKS1 |
GO:1901621 | BP | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning | Any process that stops, prevents or reduces the frequency, rate or extent of smoothened signaling pathway involved in dorsal/ventral neural tube patterning. |
TULP3, PRKACA, SUFU |
GO:1901628 | BP | positive regulation of postsynaptic membrane organization | Any process that activates or increases the frequency, rate or extent of postsynaptic membrane organization. |
APOE |
GO:1901630 | BP | negative regulation of presynaptic membrane organization | Any process that stops, prevents or reduces the frequency, rate or extent of presynaptic membrane organization. |
APOE |
GO:1901639 | BP | XDP catabolic process | The chemical reactions and pathways resulting in the breakdown of XDP. |
NUDT16 |
GO:1901642 | BP | nucleoside transmembrane transport | The directed movement of nucleoside across a membrane. |
SLC29A1 |
GO:1901652 | BP | response to peptide | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide stimulus. |
AVPR2, OXTR |
GO:1901653 | BP | cellular response to peptide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide stimulus. |
KLF4, AKR1B1, ID1, KLF3, KLF10, KLF15, KLF2 |
GO:1901657 | BP | glycosyl compound metabolic process | The chemical reactions and pathways involving glycosyl compound. |
LCT, KL |
GO:1901660 | BP | calcium ion export | The directed movement of calcium ion out of a cell or organelle. |
ATP2B1, ATP2B4 |
GO:1901661 | BP | quinone metabolic process | The chemical reactions and pathways involving quinone. |
CRYZL1 |
GO:1901666 | BP | positive regulation of NAD+ ADP-ribosyltransferase activity | Any process that activates or increases the frequency, rate or extent of NAD+ ADP-ribosyltransferase activity. |
TGFB1 |
GO:1901671 | BP | positive regulation of superoxide dismutase activity | Any process that activates or increases the frequency, rate or extent of superoxide dismutase activity. |
TNF, RGN |
GO:1901673 | BP | regulation of mitotic spindle assembly | Any process that modulates the frequency, rate or extent of mitotic spindle assembly. |
CHMP2A, VPS4B, TPR, PLK1, CHMP4B |
GO:1901676 | BP | positive regulation of histone H3-K27 acetylation | Any process that activates or increases the frequency, rate or extent of histone H3-K27 acetylation. |
LIF |
GO:1901687 | BP | glutathione derivative biosynthetic process | The chemical reactions and pathways resulting in the formation of glutathione derivative. |
MGST3, GSTA4, GSTZ1, GSTA1, GSTP1, GSTM1, MGST1, GSTM3, GSTM2, GSTT1, GSTO1, GSTM4, MGST2, GSTO2, GSTK1 |
GO:1901723 | BP | negative regulation of cell proliferation involved in kidney development | Any process that stops, prevents or reduces the frequency, rate or extent of cell proliferation involved in kidney development. |
FLCN |
GO:1901724 | BP | positive regulation of cell proliferation involved in kidney development | Any process that activates or increases the frequency, rate or extent of cell proliferation involved in kidney development. |
LIN28A |
GO:1901725 | BP | regulation of histone deacetylase activity | Any process that modulates the frequency, rate or extent of histone deacetylase activity. |
CAMK2D |
GO:1901726 | BP | negative regulation of histone deacetylase activity | Any process that stops, prevents or reduces the frequency, rate or extent of histone deacetylase activity. |
KDM5A |
GO:1901727 | BP | positive regulation of histone deacetylase activity | Any process that activates or increases the frequency, rate or extent of histone deacetylase activity. |
VEGFA, PRKD1, C6orf89, PINK1, PRKD2 |
GO:1901740 | BP | negative regulation of myoblast fusion | Any process that stops, prevents or reduces the frequency, rate or extent of myoblast fusion. |
CFLAR |
GO:1901741 | BP | positive regulation of myoblast fusion | Any process that activates or increases the frequency, rate or extent of myoblast fusion. |
FLOT1, CD53, IL4R, NFATC2, MAPK14, GDF15 |
GO:1901796 | BP | regulation of signal transduction by p53 class mediator | Any process that modulates the frequency, rate or extent of signal transduction by p53 class mediator. |
CHEK1, AURKA, MDM4, NUAK1, RAD1, NBN, MBD3, TP53, UBC, CDK2, AKT1, RPA3, RFC4, RFC2, BRCA1, RFC5, RFC3, MRE11A, DNA2, BLM, PRKAG1, PRKAA2, RPS27A, UBA52, CDK5, MDM2, SSRP1, RBBP4, EP300, TAF10, HDAC1, TP53BP2, CHD4, TAF5, TAF11, STK11, TAF12, MAPK14, RAD9B, JMY, BANP, SETD9, PPP1R13L, ATRIP, TOPBP1, DYRK2, HDAC2, KAT6A, RAD50, TP53INP1, AURKB, EHMT2, TP53RK, RAD9A, BARD1, RHNO1, PHF20, HIPK2, MEAF6, TAF9B, BRD7, KMT5A, PRKAG3, TPX2, EXO1, NOC2L, L3MBTL1, SUPT16H |
GO:1901797 | BP | negative regulation of signal transduction by p53 class mediator | Any process that stops, prevents or reduces the frequency, rate or extent of signal transduction by p53 class mediator. |
MDM2, RFFL |
GO:1901798 | BP | positive regulation of signal transduction by p53 class mediator | Any process that activates or increases the frequency, rate or extent of signal transduction by p53 class mediator. |
HEXIM1 |
GO:1901799 | BP | negative regulation of proteasomal protein catabolic process | Any process that stops, prevents or reduces the frequency, rate or extent of proteasomal protein catabolic process. |
GABARAPL2, LAMP3 |
GO:1901800 | BP | positive regulation of proteasomal protein catabolic process | Any process that activates or increases the frequency, rate or extent of proteasomal protein catabolic process. |
PARK2, XBP1, PSMC3, PSMC2, PSMC4, PSMC1, PSMC6, FMR1 |
GO:1901835 | BP | positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA | Any process that activates or increases the frequency, rate or extent of deadenylation-independent decapping of nuclear-transcribed mRNA. |
ZFP36 |
GO:1901837 | BP | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter | Any process that stops, prevents or reduces the frequency, rate or extent of transcription of nuclear large rRNA transcript from RNA polymerase I promoter. |
H2AFY, H2AFY2 |
GO:1901838 | BP | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter | Any process that activates or increases the frequency, rate or extent of transcription of nuclear large rRNA transcript from RNA polymerase I promoter. |
SMARCA4, NOL11 |
GO:1901841 | BP | regulation of high voltage-gated calcium channel activity | Any process that modulates the frequency, rate or extent of high voltage-gated calcium channel activity. |
SRI, CALM2 |
GO:1901843 | BP | positive regulation of high voltage-gated calcium channel activity | Any process that activates or increases the frequency, rate or extent of high voltage-gated calcium channel activity. |
CACNA2D1, FGF14 |
GO:1901844 | BP | regulation of cell communication by electrical coupling involved in cardiac conduction | Any process that modulates the frequency, rate or extent of cell communication by electrical coupling involved in cardiac conduction. |
SRI, CALM2, CAV1, PDE4D, CAMK2D |
GO:1901856 | BP | negative regulation of cellular respiration | Any process that stops, prevents or reduces the frequency, rate or extent of cellular respiration. |
FLCN |
GO:1901857 | BP | positive regulation of cellular respiration | Any process that activates or increases the frequency, rate or extent of cellular respiration. |
PPARGC1A, PRELID1 |
GO:1901859 | BP | negative regulation of mitochondrial DNA metabolic process | Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial DNA metabolic process. |
FLCN |
GO:1901860 | BP | positive regulation of mitochondrial DNA metabolic process | Any process that activates or increases the frequency, rate or extent of mitochondrial DNA metabolic process. |
PPARGC1A |
GO:1901862 | BP | negative regulation of muscle tissue development | Any process that stops, prevents or reduces the frequency, rate or extent of muscle tissue development. |
IGFBP5, FLCN |
GO:1901863 | BP | positive regulation of muscle tissue development | Any process that activates or increases the frequency, rate or extent of muscle tissue development. |
PPARGC1A |
GO:1901874 | BP | negative regulation of post-translational protein modification | Any process that stops, prevents or reduces the frequency, rate or extent of post-translational protein modification. |
CRTAP, FLCN |
GO:1901877 | BP | negative regulation of calcium ion binding | Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion binding. |
PLN |
GO:1901888 | BP | regulation of cell junction assembly | Any process that modulates the frequency, rate or extent of cell junction assembly. |
RAP1A, RAPGEF1 |
GO:1901890 | BP | positive regulation of cell junction assembly | Any process that activates or increases the frequency, rate or extent of cell junction assembly. |
FLOT1 |
GO:1901894 | BP | regulation of calcium-transporting ATPase activity | Any process that modulates the frequency, rate or extent of calcium-transporting ATPase activity. |
PLN |
GO:1901895 | BP | negative regulation of calcium-transporting ATPase activity | Any process that stops, prevents or reduces the frequency, rate or extent of calcium-transporting ATPase activity. |
PLN |
GO:1901896 | BP | positive regulation of calcium-transporting ATPase activity | Any process that activates or increases the frequency, rate or extent of calcium-transporting ATPase activity. |
RGN, RYR2 |
GO:1901897 | BP | regulation of relaxation of cardiac muscle | Any process that modulates the frequency, rate or extent of relaxation of cardiac muscle. |
PLN, CAMK2D |
GO:1901898 | BP | negative regulation of relaxation of cardiac muscle | Any process that stops, prevents or reduces the frequency, rate or extent of relaxation of cardiac muscle. |
PDE4D |
GO:1901907 | BP | diadenosine pentaphosphate catabolic process | The chemical reactions and pathways resulting in the breakdown of diadenosine pentaphosphate. |
NUDT3, NUDT10, NUDT11 |
GO:1901909 | BP | diadenosine hexaphosphate catabolic process | The chemical reactions and pathways resulting in the breakdown of diadenosine hexaphosphate. |
NUDT3, NUDT10, NUDT11 |
GO:1901911 | BP | adenosine 5'-(hexahydrogen pentaphosphate) catabolic process | The chemical reactions and pathways resulting in the breakdown of adenosine 5'-(hexahydrogen pentaphosphate). |
NUDT3, NUDT10, NUDT11 |
GO:1901962 | BP | S-adenosyl-L-methionine transmembrane transport | The directed movement of S-adenosyl-L-methionine across a membrane. |
SLC25A26 |
GO:1901964 | BP | positive regulation of cell proliferation involved in outflow tract morphogenesis | Any process that activates or increases the frequency, rate or extent of cell proliferation involved in outflow tract morphogenesis. |
BMP4 |
GO:1901970 | BP | positive regulation of mitotic sister chromatid separation | Any process that activates or increases the frequency, rate or extent of mitotic sister chromatid separation. |
ESPL1 |
GO:1901976 | BP | regulation of cell cycle checkpoint | Any process that modulates the frequency, rate or extent of cell cycle checkpoint. |
AKT1 |
GO:1901978 | BP | positive regulation of cell cycle checkpoint | Any process that activates or increases the frequency, rate or extent of cell cycle checkpoint. |
PROX1 |
GO:1901979 | BP | regulation of inward rectifier potassium channel activity | Any process that modulates the frequency, rate or extent of inward rectifier potassium channel activity. |
CAV1 |
GO:1901985 | BP | positive regulation of protein acetylation | Any process that activates or increases the frequency, rate or extent of protein acetylation. |
CAMK1 |
GO:1901989 | BP | positive regulation of cell cycle phase transition | Any process that activates or increases the frequency, rate or extent of cell cycle phase transition. |
CDCA5 |
GO:1901990 | BP | regulation of mitotic cell cycle phase transition | Any process that modulates the frequency, rate or extent of mitotic cell cycle phase transition. |
ERCC2, XPC, NEK11 |
GO:1901991 | BP | negative regulation of mitotic cell cycle phase transition | Any process that stops, prevents or reduces the frequency, rate or extent of mitotic cell cycle phase transition. |
ZFP36L2, ZFP36L1, TPRA1, RGCC |
GO:1901998 | BP | toxin transport | The directed movement of a toxin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
ARID1A, NRP1, LRP6, SLC22A3, HSPA5, TCP1, CASP1, DNAJA1, CCT3, CCT8, RAB28, ANTXR2, COPZ1, CCT2, BNIP3, ATP6V0A1, CCT7, SLC7A8, GGA1 |
GO:1902003 | BP | regulation of beta-amyloid formation | Any process that modulates the frequency, rate or extent of beta-amyloid formation. |
TMED10 |
GO:1902004 | BP | positive regulation of beta-amyloid formation | Any process that activates or increases the frequency, rate or extent of beta-amyloid formation. |
GSAP, CLU, CSNK1E, PICALM |
GO:1902010 | BP | negative regulation of translation in response to endoplasmic reticulum stress | Any process that stops, prevents, or reduces the frequency, rate or extent of translation as a result of endoplasmic reticulum stress. |
SESN2 |
GO:1902017 | BP | regulation of cilium assembly | Any process that modulates the frequency, rate or extent of cilium assembly. |
CYLD, DCDC2, VDAC3 |
GO:1902018 | BP | negative regulation of cilium assembly | Any process that stops, prevents or reduces the frequency, rate or extent of cilium assembly. |
EVI5L |
GO:1902031 | BP | regulation of NADP metabolic process | Any process that modulates the frequency, rate or extent of NADP metabolic process. |
ME2 |
GO:1902033 | BP | regulation of hematopoietic stem cell proliferation | Any process that modulates the frequency, rate or extent of hematopoietic stem cell proliferation. |
ACE |
GO:1902035 | BP | positive regulation of hematopoietic stem cell proliferation | Any process that activates or increases the frequency, rate or extent of hematopoietic stem cell proliferation. |
KITLG, PDCD2, N4BP2L2 |
GO:1902037 | BP | negative regulation of hematopoietic stem cell differentiation | Any process that stops, prevents or reduces the frequency, rate or extent of hematopoietic stem cell differentiation. |
N4BP2L2 |
GO:1902038 | BP | positive regulation of hematopoietic stem cell differentiation | Any process that activates or increases the frequency, rate or extent of hematopoietic stem cell differentiation. |
FOXC1 |
GO:1902041 | BP | regulation of extrinsic apoptotic signaling pathway via death domain receptors | Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. |
CFLAR, LGALS3, SP100, FAS, TNFSF10, STX4, FADD, RIPK1, CASP8, TRADD, FEM1B |
GO:1902042 | BP | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. |
CFLAR, FGA, FGB, FGG, RAF1, SERPINE1, ICAM1, GPX1, HMOX1, HGF, TNFAIP3, FAS, HMGB2, NOS3, BRCA1, TNFSF10, DAPK1, FADD, RIPK1, CASP8, PEA15, TRADD, RFFL, ARHGEF2, TMBIM1 |
GO:1902043 | BP | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. |
THBS1, SKIL, MAL, STK4, FADD, PMAIP1, PEA15, SFRP1, FAF1 |
GO:1902044 | BP | regulation of Fas signaling pathway | Any process that modulates the frequency, rate or extent of Fas signaling pathway. |
SP100 |
GO:1902045 | BP | negative regulation of Fas signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of Fas signaling pathway. |
TMBIM1 |
GO:1902065 | BP | response to L-glutamate | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an L-glutamate stimulus. |
AIFM1, PCNA, CREB1 |
GO:1902068 | BP | regulation of sphingolipid mediated signaling pathway | Any process that modulates the frequency, rate or extent of sphingolipid signaling. |
PLPP3 |
GO:1902074 | BP | response to salt | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a salt stimulus. |
EDN1, HRSP12 |
GO:1902081 | BP | negative regulation of calcium ion import into sarcoplasmic reticulum | Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion import into sarcoplasmic reticulum. |
PLN |
GO:1902083 | BP | negative regulation of peptidyl-cysteine S-nitrosylation | Any process that stops, prevents or reduces the frequency, rate or extent of peptidyl-cysteine S-nitrosylation. |
DMD, ATP2B4, SNTA1 |
GO:1902108 | BP | regulation of mitochondrial membrane permeability involved in apoptotic process | Any regulation of mitochondrial membrane permeability that is involved in apoptotic process. |
THEM4 |
GO:1902109 | BP | negative regulation of mitochondrial membrane permeability involved in apoptotic process | Any negative regulation of mitochondrial membrane permeability that is involved in apoptotic process. |
NOL3 |
GO:1902115 | BP | regulation of organelle assembly | Any process that modulates the frequency, rate or extent of organelle assembly. |
EZR, RDX |
GO:1902161 | BP | positive regulation of cyclic nucleotide-gated ion channel activity | Any process that activates or increases the frequency, rate or extent of cyclic nucleotide-gated ion channel activity. |
CFTR |
GO:1902166 | BP | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator. |
TRIAP1, KDM1A, CD74, MIF, MUC1, CD44, BCL2L12, TAF9B |
GO:1902170 | BP | cellular response to reactive nitrogen species | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive nitrogen species stimulus. |
MAP3K5 |
GO:1902172 | BP | regulation of keratinocyte apoptotic process | Any process that modulates the frequency, rate or extent of keratinocyte apoptotic process. |
ZFP36, ZFP36L1 |
GO:1902173 | BP | negative regulation of keratinocyte apoptotic process | Any process that stops, prevents or reduces the frequency, rate or extent of keratinocyte apoptotic process. |
SERPINB13 |
GO:1902174 | BP | positive regulation of keratinocyte apoptotic process | Any process that activates or increases the frequency, rate or extent of keratinocyte apoptotic process. |
SFRP4 |
GO:1902175 | BP | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | Any process that modulates the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway. |
P4HB |